How to buy Synlogic stock | 2.07

Synlogic, Inc is a biotechnology business based in the US. Synlogic shares (SYBX) are listed on the NASDAQ and all prices are listed in US Dollars. Synlogic employs 76 staff and has a trailing 12-month revenue of around USD$1.8 million.

How to buy shares in Synlogic

1. Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
3. Search for Synlogic. Find the stock by name or ticker symbol: SYBX. Research its history to confirm it's a solid investment against your financial goals.
4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Synlogic reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
5. Decide on how many to buy. At last close price of USD$2.07, weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of Synlogic, depending on your broker.
6. Check in on your investment. Congratulations, you own a part of Synlogic. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

Synlogic share price

Use our graph to track the performance of SYBX stocks over time.

Synlogic shares at a glance

• Key figures

Information last updated 2020-11-25.

Latest market close	USD$2.07
52-week range	USD$1.35 - USD$3.46
50-day moving average	USD$2.0231
200-day moving average	USD$2.1572
Wall St. target price	USD$8
PE ratio	N/A
Dividend yield	N/A (0%)
Earnings per share (TTM)	USD$-1.861

Buy Synlogic shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.

Is it a good time to buy Synlogic stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Technical Analysis of Synlogic, Inc by TradingView

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Synlogic price performance over time

Historical closes compared with the close of $2.07 from 2020-11-16

1 week (2020-11-19)	N/A
1 month (2020-10-26)	N/A
3 months (2020-08-26)	N/A
6 months (2020-05-26)	N/A

1 year (2019-11-26)	N/A
2 years (2018-11-26)	N/A
3 years (2017-11-26)	N/A
5 years (2015-11-26)	N/A

Synlogic financials

Revenue TTM	USD$1.8 million
Gross profit TTM	USD$-14,641,000
Return on assets TTM	-21.11%
Return on equity TTM	-39.69%
Profit margin	0%
Book value	$3.475
Market capitalisation	USD$76.3 million

TTM: trailing 12 months

Shorting Synlogic shares

There are currently 393,560 Synlogic shares held short by investors – that's known as Synlogic's "short interest". This figure is 49.1% up from 263,954 last month.

There are a few different ways that this level of interest in shorting Synlogic shares can be evaluated.

Synlogic's "short interest ratio" (SIR)

Synlogic's "short interest ratio" (SIR) is the quantity of Synlogic shares currently shorted divided by the average quantity of Synlogic shares traded daily (recently around 143112.72727273). Synlogic's SIR currently stands at 2.75. In other words for every 100,000 Synlogic shares traded daily on the market, roughly 2750 shares are currently held short.

However Synlogic's short interest can also be evaluated against the total number of Synlogic shares, or, against the total number of tradable Synlogic shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Synlogic's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 Synlogic shares in existence, roughly 10 shares are currently held short) or 0.0209% of the tradable shares (for every 100,000 tradable Synlogic shares, roughly 21 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Synlogic.

Find out more about how you can short Synlogic stock.

Synlogic share dividends

We're not expecting Synlogic to pay a dividend over the next 12 months.

Have Synlogic's shares ever split?

Synlogic's shares were split on a 1:7 basis on 28 August 2017. So if you had owned 7 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Synlogic shares – just the quantity. However, indirectly, the new 600% higher share price could have impacted the market appetite for Synlogic shares which in turn could have impacted Synlogic's share price.

Synlogic share price volatility

Over the last 12 months, Synlogic's shares have ranged in value from as little as $1.35 up to $3.46. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Synlogic's is 1.9364. This would suggest that Synlogic's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Synlogic overview

Synlogic, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of synthetic biotic medicines to treat metabolic, inflammatory, and cancer diseases in the United States. Its therapeutic programs include SYNB1618, an oral therapy that is in Phase I/IIa clinical trial to treat phenylketonuria. The company is also developing SYNB1891, an intratumorally administered synthetic biotic medicine that is in Phase I clinical trial to treat solid tumors and lymphoma. It has a collaboration agreement with Ginkgo Bioworks for the development of synthetic biotic medicines. Synlogic, Inc. is headquartered in Cambridge, Massachusetts.

Frequently asked questions

• What percentage of Synlogic is owned by insiders or institutions?

  Currently 19.019% of Synlogic shares are held by insiders and 39.884% by institutions.

• How many people work for Synlogic?

  Latest data suggests 76 work at Synlogic.

• When does the fiscal year end for Synlogic?

  Synlogic's fiscal year ends in December.

• Where is Synlogic based?

  Synlogic's address is: 301 Binney Street, Cambridge, MA, United States, 02142

• What is Synlogic's ISIN number?

  Synlogic's international securities identification number is: US87166L1008

• What is Synlogic's CUSIP number?

  Synlogic's Committee on Uniform Securities Identification Procedures number is: 60470J103